Literature DB >> 25893599

Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.

Hemanth Tummala, Amanda Walne, Laura Collopy, Shirleny Cardoso, Josu de la Fuente, Sarah Lawson, James Powell, Nicola Cooper, Alison Foster, Shehla Mohammed, Vincent Plagnol, Thomas Vulliamy, Inderjeet Dokal.   

Abstract

Dyskeratosis congenita (DC) and related syndromes are inherited, life-threatening bone marrow (BM) failure disorders, and approximately 40% of cases are currently uncharacterized at the genetic level. Here, using whole exome sequencing (WES), we have identified biallelic mutations in the gene encoding poly(A)-specific ribonuclease (PARN) in 3 families with individuals exhibiting severe DC. PARN is an extensively characterized exonuclease with deadenylation activity that controls mRNA stability in part and therefore regulates expression of a large number of genes. The DC-associated mutations identified affect key domains within the protein, and evaluation of patient cells revealed reduced deadenylation activity. This deadenylation deficiency caused an early DNA damage response in terms of nuclear p53 regulation, cell-cycle arrest, and reduced cell viability upon UV treatment. Individuals with biallelic PARN mutations and PARN-depleted cells exhibited reduced RNA levels for several key genes that are associated with telomere biology, specifically TERC, DKC1, RTEL1, and TERF1. Moreover, PARN-deficient cells also possessed critically short telomeres. Collectively, these results identify a role for PARN in telomere maintenance and demonstrate that it is a disease-causing gene in a subset of patients with severe DC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893599      PMCID: PMC4463202          DOI: 10.1172/JCI78963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression.

Authors:  F E Kleiman; J L Manley
Journal:  Cell       Date:  2001-03-09       Impact factor: 41.582

3.  Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitro.

Authors:  M Gao; D T Fritz; L P Ford; J Wilusz
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

4.  The mRNA cap structure stimulates rate of poly(A) removal and amplifies processivity of degradation.

Authors:  J Martînez; Y G Ren; P Nilsson; M Ehrenberg; A Virtanen
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

Review 5.  Dyskerin, telomerase and the DNA damage response.

Authors:  BaiWei Gu; Monica Bessler; Philip J Mason
Journal:  Cell Cycle       Date:  2009-01-24       Impact factor: 4.534

6.  Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1.

Authors:  S W Knight; N S Heiss; T J Vulliamy; C M Aalfs; C McMahon; P Richmond; A Jones; R C Hennekam; A Poustka; P J Mason; I Dokal
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

Review 7.  mRNA stability in eukaryotes.

Authors:  P Mitchell; D Tollervey
Journal:  Curr Opin Genet Dev       Date:  2000-04       Impact factor: 5.578

8.  Cap-dependent deadenylation of mRNA.

Authors:  E Dehlin; M Wormington; C G Körner; E Wahle
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

9.  Nonsense-mediated mRNA decay in mammalian cells involves decapping, deadenylating, and exonucleolytic activities.

Authors:  Fabrice Lejeune; Xiaojie Li; Lynne E Maquat
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

10.  Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1.

Authors:  Yiran Guo; Melissa Kartawinata; Jiankang Li; Hilda A Pickett; Juliana Teo; Tatjana Kilo; Pasquale M Barbaro; Brendan Keating; Yulan Chen; Lifeng Tian; Ahmad Al-Odaib; Roger R Reddel; John Christodoulou; Xun Xu; Hakon Hakonarson; Tracy M Bryan
Journal:  Blood       Date:  2014-09-09       Impact factor: 25.476

View more
  91 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

Review 2.  Neonatal manifestations of inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Fetal Neonatal Med       Date:  2015-12-24       Impact factor: 3.926

3.  Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.

Authors:  Neha Nagpal; Jianing Wang; Jing Zeng; Emily Lo; Diane H Moon; Kevin Luk; Roman O Braun; Lauri M Burroughs; Sioban B Keel; Christopher Reilly; R Coleman Lindsley; Scot A Wolfe; Albert K Tai; Patrick Cahan; Daniel E Bauer; Yick W Fong; Suneet Agarwal
Journal:  Cell Stem Cell       Date:  2020-04-21       Impact factor: 24.633

4.  Disruption of Telomerase RNA Maturation Kinetics Precipitates Disease.

Authors:  Caitlin M Roake; Lu Chen; Ananya L Chakravarthy; James E Ferrell; Grazia D Raffa; Steven E Artandi
Journal:  Mol Cell       Date:  2019-03-28       Impact factor: 17.970

Review 5.  Telomerase Mechanism of Telomere Synthesis.

Authors:  R Alex Wu; Heather E Upton; Jacob M Vogan; Kathleen Collins
Journal:  Annu Rev Biochem       Date:  2017-01-30       Impact factor: 23.643

6.  Epigenetic inheritance of telomere length obscures identification of causative PARN locus.

Authors:  Chao Xing; Christine Kim Garcia
Journal:  J Med Genet       Date:  2016-02-23       Impact factor: 6.318

7.  Homozygous Rare PARN Missense Mutation in Familial Pulmonary Fibrosis.

Authors:  David Zhang; Zhengyang Zhou; Muhanned Abu-Hijleh; Kiran Batra; Chao Xing; Christine Kim Garcia
Journal:  Am J Respir Crit Care Med       Date:  2019-03-15       Impact factor: 21.405

8.  Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families.

Authors:  Jonathan A Kropski; Sara Reiss; Cheryl Markin; Kevin K Brown; David A Schwartz; Marvin I Schwarz; James E Loyd; John A Phillips; Timothy S Blackwell; Joy D Cogan
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

Review 9.  Expanding the repertoire of deadenylases.

Authors:  Ilias Skeparnias; Dimitrios Αnastasakis; Athanasios-Nasir Shaukat; Katerina Grafanaki; Constantinos Stathopoulos
Journal:  RNA Biol       Date:  2017-03-07       Impact factor: 4.652

10.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.